Velopalatine and Bilateral Vocal Cord Paralysis Associated with Atezolizumab Treatment: A Severe and Previously Undocumented Side Effect in Cancer Immunotherapy
This study identifies a novel unreported adverse effect —bilateral vocal cord and velopalatine paralysis—associated with atezolizumab use.
Source: Indian Journal of Otolaryngology and Head and Neck Surgery - Category: ENT & OMF Source Type: research
More News: Cancer | Cancer & Oncology | ENT & OMF | Head and Neck Cancer | Immunotherapy | India Health | Study